Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

A qualitative study of barriers to genetic counseling and potential for mobile technology education among women with ovarian cancer.

Vogel RI, Niendorf K, Lee H, Petzel S, Lee HY, Geller MA.

Hered Cancer Clin Pract. 2018 Jul 4;16:13. doi: 10.1186/s13053-018-0095-z. eCollection 2018.

2.

Chemotherapy-Induced Tunneling Nanotubes Mediate Intercellular Drug Efflux in Pancreatic Cancer.

Desir S, O'Hare P, Vogel RI, Sperduto W, Sarkari A, Dickson EL, Wong P, Nelson AC, Fong Y, Steer CJ, Subramanian S, Lou E.

Sci Rep. 2018 Jun 21;8(1):9484. doi: 10.1038/s41598-018-27649-x.

3.

Effect of intra-operative glove changing during cesarean section on post-operative complications: a randomized controlled trial.

Scrafford JD, Reddy B, Rivard C, Vogel RI.

Arch Gynecol Obstet. 2018 Jun;297(6):1449-1454. doi: 10.1007/s00404-018-4748-y. Epub 2018 Mar 19.

PMID:
29556706
4.

A pilot investigation on impact of participation in a long-term follow-up clinic (LTFU) on breast cancer and cardiovascular screening among women who received chest radiation for Hodgkin lymphoma.

Baxstrom K, Peterson BA, Lee C, Vogel RI, Blaes AH.

Support Care Cancer. 2018 Jul;26(7):2361-2368. doi: 10.1007/s00520-018-4072-x. Epub 2018 Feb 7.

PMID:
29417294
5.

Assessment of Circulating Tumor Cells as a Predictive Biomarker of Histology in Women With Suspected Ovarian Cancer.

Lou E, Vogel RI, Teoh D, Hoostal S, Grad A, Gerber M, Monu M, Lukaszewski T, Deshpande J, Linden MA, Geller MA.

Lab Med. 2018 Mar 21;49(2):134-139. doi: 10.1093/labmed/lmx084.

PMID:
29361118
6.

A Cross-Sectional Review of Cervical Cancer Messages on Twitter During Cervical Cancer Awareness Month.

Teoh D, Shaikh R, Vogel RI, Zoellner T, Carson L, Kulasingam S, Lou E.

J Low Genit Tract Dis. 2018 Jan;22(1):8-12. doi: 10.1097/LGT.0000000000000363.

PMID:
29271850
7.

Patterns of postpartum contraceptive use among Somali immigrant women living in Minnesota.

Millar A, Vogel RI, Bedell S, Ayers Looby M, Hubbs JL, Harlow BL, Ghebre R.

Contracept Reprod Med. 2017 Apr 4;2:14. doi: 10.1186/s40834-017-0041-x. eCollection 2017.

8.

Prophylactic Negative Pressure Wound Therapy in Obese Patients Following Cesarean Delivery.

Looby MA, Vogel RI, Bangdiwala A, Hyer B, Das K.

Surg Innov. 2018 Feb;25(1):43-49. doi: 10.1177/1553350617736652. Epub 2017 Nov 1.

PMID:
29090986
9.

A Qualitative Study of Quality of Life Concerns following a Melanoma Diagnosis.

Vogel RI, Strayer LG, Ahmed RL, Blaes A, Lazovich D.

J Skin Cancer. 2017;2017:2041872. doi: 10.1155/2017/2041872. Epub 2017 May 28.

10.

Assessment of the Intraoperative Consultation Service Rendered by General Pathologists in a Scenario Where a Well-Defined Decision Algorithm Is Followed.

Khalifa MA, Salama S, Vogel RI, Klein ME, Richter J, Pulver T, Mullany SA, Winterhoff B.

Am J Clin Pathol. 2017 Mar 1;147(3):322-326. doi: 10.1093/ajcp/aqw223.

PMID:
28395052
11.

UNC-45A is required for neurite extension via controlling NMII activation.

Iizuka Y, Mooneyham A, Sieben A, Chen K, Maile M, Hellweg R, Schütz F, Teckle K, Starr T, Thayanithy V, Vogel RI, Lou E, Lee MK, Bazzaro M.

Mol Biol Cell. 2017 May 15;28(10):1337-1346. doi: 10.1091/mbc.E16-06-0381. Epub 2017 Mar 29.

12.

Sun Exposure and Protection Behaviors among Long-term Melanoma Survivors and Population Controls.

Vogel RI, Strayer LG, Engelman L, Nelson HH, Blaes AH, Anderson KE, Lazovich D.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):607-613. doi: 10.1158/1055-9965.EPI-16-0854. Epub 2017 Mar 2.

13.

Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study.

Vogel RI, Strayer LG, Engelman L, Nelson HH, Blaes AH, Anderson KE, Lazovich D.

Qual Life Res. 2017 Jul;26(7):1761-1766. doi: 10.1007/s11136-017-1532-6. Epub 2017 Feb 27.

14.

CK2 Molecular Targeting-Tumor Cell-Specific Delivery of RNAi in Various Models of Cancer.

Trembley JH, Kren BT, Abedin MJ, Vogel RI, Cannon CM, Unger GM, Ahmed K.

Pharmaceuticals (Basel). 2017 Feb 21;10(1). pii: E25. doi: 10.3390/ph10010025. Review.

15.

Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled Trial.

Dickson EL, Stockwell E, Geller MA, Vogel RI, Mullany SA, Ghebre R, Witherhoff BJ, Downs LS Jr, Carson LF, Teoh D, Glasgow M, Gerber M, Rivard C, Erickson BK, Hutchins J, Argenta PA.

Obstet Gynecol. 2017 Feb;129(2):355-362. doi: 10.1097/AOG.0000000000001838.

PMID:
28079776
16.

Early elective delivery and vaginal birth after cesarean in rural US maternity hospitals.

Heinrich D, Vogel RI, Kozhimannil KB.

Rural Remote Health. 2016 Oct-Dec;16(4):3956. Epub 2016 Nov 15.

17.

Prognostic factors for survival in advanced appendiceal cancers.

Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E.

Cancer Biomark. 2016;17(4):457-462. doi: 10.3233/CBM-160662.

18.

Evaluation of the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator in Gynecologic Oncology Patients Undergoing Minimally Invasive Surgery.

Teoh D, Halloway RN, Heim J, Vogel RI, Rivard C.

J Minim Invasive Gynecol. 2017 Jan 1;24(1):48-54. doi: 10.1016/j.jmig.2016.10.005. Epub 2016 Oct 24.

PMID:
27789387
19.

Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats.

LeSage MG, Staley M, Muelken P, Smethells JR, Stepanov I, Vogel RI, Pentel PR, Harris AC.

Drug Alcohol Depend. 2016 Nov 1;168:76-88. doi: 10.1016/j.drugalcdep.2016.08.628. Epub 2016 Sep 1.

20.

Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.

Allen A, Vogel RI, Meier E, Anderson A, Jensen J, Severson HH, Hatsukami D.

Drug Alcohol Depend. 2016 Nov 1;168:8-12. doi: 10.1016/j.drugalcdep.2016.08.624. Epub 2016 Aug 28.

21.

The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.

Law EK, Sieuwerts AM, LaPara K, Leonard B, Starrett GJ, Molan AM, Temiz NA, Vogel RI, Meijer-van Gelder ME, Sweep FC, Span PN, Foekens JA, Martens JW, Yee D, Harris RS.

Sci Adv. 2016 Oct 7;2(10):e1601737. eCollection 2016 Oct.

22.

CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.

Ahmed K, Kren BT, Abedin MJ, Vogel RI, Shaughnessy DP, Nacusi L, Korman VL, Li Y, Dehm SM, Zimmerman CL, Niehans GA, Unger GM, Trembley JH.

Oncotarget. 2016 Sep 20;7(38):61789-61805. doi: 10.18632/oncotarget.11442.

23.

Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports.

Ji Y, Vogel RI, Lou E.

Neurooncol Pract. 2016 Sep;3(3):188-195. Epub 2015 Nov 12.

24.

Long term follow-up of a phase II trial of multimodal therapy given in a "sandwich" method for stage III, IV, and recurrent endometrial cancer.

Glasgow M, Vogel RI, Burgart J, Argenta P, Dusenbery K, Geller MA.

Gynecol Oncol Res Pract. 2016 May 26;3:6. doi: 10.1186/s40661-016-0027-4. eCollection 2016.

25.

Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer.

Rizzardi AE, Zhang X, Vogel RI, Kolb S, Geybels MS, Leung YK, Henriksen JC, Ho SM, Kwak J, Stanford JL, Schmechel SC.

Diagn Pathol. 2016 Jul 11;11(1):63. doi: 10.1186/s13000-016-0511-5.

26.

A model for patient-direct screening and referral for familial cancer risk.

Niendorf KB, Geller MA, Vogel RI, Church TR, Leininger A, Bakke A, Madoff RD.

Fam Cancer. 2016 Oct;15(4):707-16. doi: 10.1007/s10689-016-9912-6.

27.

Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells.

Desir S, Dickson EL, Vogel RI, Thayanithy V, Wong P, Teoh D, Geller MA, Steer CJ, Subramanian S, Lou E.

Oncotarget. 2016 Jul 12;7(28):43150-43161. doi: 10.18632/oncotarget.9504.

28.

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment.

Vogel RI, Pulver T, Heilmann W, Mooneyham A, Mullany S, Zhao X, Shahi M, Richter J, Klein M, Chen L, Ding R, Konecny G, Kommoss S, Winterhoff B, Ghebre R, Bazzaro M.

Oncotarget. 2016 May 24;7(21):30962-76. doi: 10.18632/oncotarget.8821.

29.

Designing an Educational Website to Improve Quality of Supportive Oncology Care for Women with Ovarian Cancer: An Expert Usability Review and Analysis.

McClellan MA, Karumur RP, Vogel RI, Petzel SV, Cragg J, Chan D, Jacko JA, Sainfort F, Geller MA.

Int J Hum Comput Interact. 2016;32(4):297-307. Epub 2016 Jan 11.

30.

Predictors of Adherence to Nicotine Replacement Therapy (Nicotine Patch) Among Homeless Persons Enrolled in a Randomized Controlled Trial Targeting Smoking Cessation.

Ojo-Fati O, Thomas JL, Vogel RI, Ogedegbe O, Jean-Louis G, Okuyemi KS.

J Fam Med. 2016;3(7). pii: 1079. Epub 2016 Sep 6.

31.

Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.

Hermanson DL, Bendzick L, Pribyl L, McCullar V, Vogel RI, Miller JS, Geller MA, Kaufman DS.

Stem Cells. 2016 Jan;34(1):93-101. doi: 10.1002/stem.2230. Epub 2015 Dec 6.

32.

Antibiotic Use after Free Tissue Reconstruction of Head and Neck Defects: Short Course vs. Long Course.

Khariwala SS, Le B, Pierce BH, Vogel RI, Chipman JG.

Surg Infect (Larchmt). 2016 Feb;17(1):100-5. doi: 10.1089/sur.2015.131. Epub 2015 Oct 26.

33.

Bile Acid Determination after Standardized Glucose Load in Pregnant Women.

Adams A, Jacobs K, Vogel RI, Lupo V.

AJP Rep. 2015 Oct;5(2):e168-71. doi: 10.1055/s-0035-1555128. Epub 2015 Jun 19.

34.

Perceived Health Risks of Snus and Medicinal Nicotine Products.

Hatsukami DK, Vogel RI, Severson HH, Jensen JA, O'Connor RJ.

Nicotine Tob Res. 2016 May;18(5):794-800. doi: 10.1093/ntr/ntv200. Epub 2015 Sep 18.

35.

A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.

Dickson EL, Vogel RI, Gehrig PA, Pierce S, Havrilesky L, Secord AA, Dottino J, Fader AN, Ricci S, Geller MA.

Gynecol Oncol. 2015 Nov;139(2):275-82. doi: 10.1016/j.ygyno.2015.09.002. Epub 2015 Sep 6.

36.

Effect of Intraperitoneal Bupivacaine on Postoperative Pain in the Gynecologic Oncology Patient.

Rivard C, Vogel RI, Teoh D.

J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1260-5. doi: 10.1016/j.jmig.2015.07.013. Epub 2015 Jul 26.

37.

Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective randomized controlled study.

Hutchins J, Delaney D, Vogel RI, Ghebre RG, Downs LS Jr, Carson L, Mullany S, Teoh D, Geller MA.

Gynecol Oncol. 2015 Sep;138(3):609-13. doi: 10.1016/j.ygyno.2015.06.008. Epub 2015 Jun 6.

38.

Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.

Hatsukami DK, Severson H, Anderson A, Vogel RI, Jensen J, Broadbent B, Murphy SE, Carmella S, Hecht SS.

Tob Control. 2016 May;25(3):267-74. doi: 10.1136/tobaccocontrol-2014-052080. Epub 2015 May 19.

39.

Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.

Kren BT, Unger GM, Abedin MJ, Vogel RI, Henzler CM, Ahmed K, Trembley JH.

Breast Cancer Res. 2015;17:19. doi: 10.1186/s13058-015-0524-0. Epub 2015 Feb 11.

40.

Ultrasound-guided subcostal transversus abdominis plane infiltration with liposomal bupivacaine for patients undergoing robotic-assisted hysterectomy: a retrospective study.

Hutchins J, Vogel RI, Ghebre R, McNally A, Downs LS Jr, Gryzmala E, Geller MA.

Int J Gynecol Cancer. 2015 Jun;25(5):937-41. doi: 10.1097/IGC.0000000000000429.

41.

Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells.

Vogel RI, Coughlin K, Scotti A, Iizuka Y, Anchoori R, Roden RB, Marastoni M, Bazzaro M.

Oncotarget. 2015 Feb 28;6(6):4159-70.

42.

Recent trends in type-specific HPV infection rates in the United States.

Dickson EL, Vogel RI, Luo X, Downs LS.

Epidemiol Infect. 2015 Apr;143(5):1042-7. doi: 10.1017/S0950268814001538.

43.

Cervical cancer screening with clinic-based Pap test versus home HPV test among Somali immigrant women in Minnesota: a pilot randomized controlled trial.

Sewali B, Okuyemi KS, Askhir A, Belinson J, Vogel RI, Joseph A, Ghebre RG.

Cancer Med. 2015 Apr;4(4):620-31. doi: 10.1002/cam4.429. Epub 2015 Feb 4.

44.

Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation.

Harris AC, Tally L, Schmidt CE, Muelken P, Stepanov I, Saha S, Vogel RI, LeSage MG.

Drug Alcohol Depend. 2015 Feb 1;147:60-7. doi: 10.1016/j.drugalcdep.2014.12.015. Epub 2014 Dec 23.

45.

Intercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes.

Ady JW, Desir S, Thayanithy V, Vogel RI, Moreira AL, Downey RJ, Fong Y, Manova-Todorova K, Moore MA, Lou E.

Front Physiol. 2014 Oct 31;5:400. doi: 10.3389/fphys.2014.00400. eCollection 2014.

46.

Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers.

Hecht SS, Carmella SG, Kotandeniya D, Pillsbury ME, Chen M, Ransom BW, Vogel RI, Thompson E, Murphy SE, Hatsukami DK.

Nicotine Tob Res. 2015 Jun;17(6):704-9. doi: 10.1093/ntr/ntu218. Epub 2014 Oct 21.

47.

Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice.

Trembley JH, Unger GM, Korman VL, Abedin MJ, Nacusi LP, Vogel RI, Slaton JW, Kren BT, Ahmed K.

PLoS One. 2014 Oct 15;9(10):e109970. doi: 10.1371/journal.pone.0109970. eCollection 2014.

48.

Parental military service, agent orange exposure, and the risk of rhabdomyosarcoma in offspring.

Grufferman S, Lupo PJ, Vogel RI, Danysh HE, Erhardt EB, Ognjanovic S.

J Pediatr. 2014 Dec;165(6):1216-21. doi: 10.1016/j.jpeds.2014.08.009. Epub 2014 Sep 17.

49.

Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.

Rivard C, Geller M, Schnettler E, Saluja M, Vogel RI, Saluja A, Ramakrishnan S.

Gynecol Oncol. 2014 Nov;135(2):318-24. doi: 10.1016/j.ygyno.2014.08.031. Epub 2014 Aug 27.

50.

Indoor tanning in businesses and homes and risk of melanoma and nonmelanoma skin cancer in 2 US case-control studies.

Ferrucci LM, Vogel RI, Cartmel B, Lazovich D, Mayne ST.

J Am Acad Dermatol. 2014 Nov;71(5):882-7. doi: 10.1016/j.jaad.2014.06.046. Epub 2014 Jul 23.

Supplemental Content

Loading ...
Support Center